Phase II and pharmacodynamic study of autophagy inhibition using hydroxychloroquine in patients with metastatic pancreatic adenocarcinoma.
about
Pancreatic cancer from bench to bedside: molecular pathways and treatment optionsKRAS Mutant Pancreatic Cancer: No Lone Path to an Effective TreatmentLeaving the lysosome behind: novel developments in autophagy inhibitionPancreatic Cancer Metabolism: Breaking It Down to Build It Back UpThe different roles of selective autophagic protein degradation in mammalian cellsAmino acid management in cancerChloroquine and hydroxychloroquine for cancer therapyAutophagy in malignant transformation and cancer progressionEmerging strategies to effectively target autophagy in cancerMacropinocytosis Exploitation by Cancers and Cancer TherapeuticsAutophagy- An emerging target for melanoma therapyTherapeutic Targeting of AutophagyNanomedicine strategies to overcome the pathophysiological barriers of pancreatic cancer.Reactive oxygen species and autophagy modulation in non-marine drugs and marine drugs.Autophagy and its effects: making sense of double-edged swords.The receptor for advanced glycation end products (RAGE) enhances autophagy and neutrophil extracellular traps in pancreatic cancer.Transforming Growth Factor TGFβ Increases Levels of Microtubule-Associated Protein MAP1S and Autophagy Flux in Pancreatic Ductal AdenocarcinomasSafety and Biologic Response of Pre-operative Autophagy Inhibition in Combination with Gemcitabine in Patients with Pancreatic Adenocarcinoma.Therapeutic Approaches to RAS Mutation.Recent insights into the function of autophagy in cancer.Antitumor adaptive immunity remains intact following inhibition of autophagy and antimalarial treatment.Autophagy-dependent danger signaling and adaptive immunity to poorly immunogenic tumors.Cellular and metabolic functions for autophagy in cancer cells.Metabolic Dependencies in RAS-Driven Cancers.Targeting cancer cell metabolism in pancreatic adenocarcinoma.Lysosomal Biology in Cancer.Clinical relevance of autophagic therapy in cancer: Investigating the current trends, challenges, and future prospects.Targeting metabolic reprogramming in KRAS-driven cancers.Autophagy in 5-Fluorouracil Therapy in Gastrointestinal Cancer: Trends and Challenges.Activating autophagy to potentiate immunogenic chemotherapy and radiation therapy.Oxidative pentose phosphate pathway inhibition is a key determinant of antimalarial induced cancer cell death.Molecular Pathways Controlling Autophagy in Pancreatic Cancer.Research progress of hydroxychloroquine and autophagy inhibitors on cancer.Hydroxychloroquine retinopathy.Autophagy and Tumor Metabolism.Targeting Autophagy in Cancer: Update on Clinical Trials and Novel Inhibitors.Autophagy Inhibition Dysregulates TBK1 Signaling and Promotes Pancreatic Inflammation.Selective cytotoxicity of vanadium complexes on human pancreatic ductal adenocarcinoma cell line by inducing necroptosis, apoptosis and mitotic catastrophe process.A unified approach to targeting the lysosome's degradative and growth signaling roles.Targeting autophagy in cancer.
P2860
Q26747524-A7ABB956-A2D5-4D43-9FEE-84F4D3537137Q26751520-062F2EC9-0078-4244-8CE3-A25FE68960C7Q26774549-1131F875-D9D3-4470-B651-9493F196C297Q26780372-C71DE066-D354-42F2-B253-F98E96AFB54FQ26785503-29201944-B500-4BC0-8E7F-22DCE08C1B10Q26798087-46338B3A-892E-405C-B1A5-EAD3AA140D2BQ26827797-A6B8A207-DCE8-455E-89ED-20AF754DA12AQ27000191-04FDE656-C3A5-454D-BB79-50CE51C8781DQ27009194-B87AAD77-8AC8-4F9E-8CB9-5C682C50313DQ28069487-C925E639-3B98-484C-818E-02BF40C2A723Q28071400-C2A7ACB3-C789-41C1-9379-71CA5B544AC8Q28078117-B0EB686C-1694-4B55-BE58-FB7CF99A7DD3Q34537580-57FA952D-8419-4D2B-AE68-D6308A3B3EB3Q34577847-4D683E40-2937-457E-B071-1D76930274B5Q35330324-D460921B-C25F-4FBE-9EE4-A32335327E5AQ35752134-1731BC3B-84FC-43AF-AD55-6907BC6ACA36Q35841939-783BEEA4-6A97-42A3-9CF9-AF6CE50E35B7Q36329393-DC524ECB-C952-4D6D-8215-11F66BB813FEQ37122874-72880566-CA48-4994-B4CE-E9B7C4D284ACQ37343004-B79085D2-6590-44F8-883C-5368FF99AE3CQ37452252-6FE84BC9-53C7-4C0B-9C60-D3F796276414Q37701461-E43CB8BB-2428-482D-BD84-61263DB3CBE7Q38256306-8C52CB87-265C-4B75-A2FD-D4DD6AF5EC90Q38423050-E4250DB2-6D16-4C7F-BEF8-1E50974A28AFQ38545275-9E7ED3DB-26EA-4676-A634-B7AA796FA4ADQ38689342-A38AEE47-7F15-47BF-9087-74BDC86DB8C6Q38689955-946FC514-914B-496D-A8E1-D564784A7C60Q38710288-335E3FF2-277F-436F-A483-13EDE986389DQ38734363-8C5C242E-7E48-4B95-B621-75F6756D8036Q38795278-A687C675-ECB3-4E3E-A72A-FCC55C7132C3Q38830428-DD64596D-5515-4DBA-967E-008F16310113Q38895232-024F7F3B-C5E8-49EC-BD13-F1DCAB257AD0Q39021076-EE7E98C8-ED3A-4A58-8C1D-5E962A4B2DB3Q39172826-E2D8A60F-851B-44AC-B6F8-A26CA637BBF3Q39280823-3CC449F4-C94A-401D-AEB2-A4D580A9D180Q39378223-DB0A1013-987D-43E2-B62B-DAB5A11C1691Q40805952-A828C47B-68FA-46C8-B48B-5A70D3D0BB51Q41694174-9214C069-C7F7-46E1-9218-61E82D31BAA1Q41911972-C0349A97-9B8A-4564-8A6C-6A7E88DE6C9CQ41912265-A95D0FE3-CC4A-495D-B807-C7B461611A4E
P2860
Phase II and pharmacodynamic study of autophagy inhibition using hydroxychloroquine in patients with metastatic pancreatic adenocarcinoma.
description
2014 nî lūn-bûn
@nan
2014 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Phase II and pharmacodynamic s ...... tic pancreatic adenocarcinoma.
@ast
Phase II and pharmacodynamic s ...... tic pancreatic adenocarcinoma.
@en
type
label
Phase II and pharmacodynamic s ...... tic pancreatic adenocarcinoma.
@ast
Phase II and pharmacodynamic s ...... tic pancreatic adenocarcinoma.
@en
prefLabel
Phase II and pharmacodynamic s ...... tic pancreatic adenocarcinoma.
@ast
Phase II and pharmacodynamic s ...... tic pancreatic adenocarcinoma.
@en
P2093
P921
P1433
P1476
Phase II and pharmacodynamic s ...... tic pancreatic adenocarcinoma.
@en
P2093
Alec C Kimmelman
Allison L Sikora
Beverly A Spicer
Brian M Wolpin
Deborah Schrag
Douglas A Rubinson
Harvey Mamon
James M Cleary
Jennifer A Chan
P304
P356
10.1634/THEONCOLOGIST.2014-0086
P577
2014-05-12T00:00:00Z